COVID-19 Vaccines for People With Kidney Disease

Introduction:

Vaccines are among the most effective ways to protect health and prevent disease. Vaccines work with the body's natural defenses so that the body is ready to fight the virus when exposed (also called immunity). Although the COVID-19 vaccine has a great efficacy rate, antibody immunity is not available in people taking immunosuppressive drugs to treat advanced kidney disease or in people who have had a kidney transplant. It is known that those people may not receive the same level of protection as people who are not taking immunosuppressants are affected by the COVID-19 vaccine. More research is needed to know more about the efficacy of vaccines for patients with advanced chronic kidney disease (CKD), people on dialysis, and transplant patients. Still, these vaccines are considered safe for this group of people. The National Kidney Foundation recommends that patients with advanced stages of kidney disease, including transplant patients and dialysis patients or those who require immunosuppression to treat advanced kidney disease, wear masks even after being fully vaccinated. They are urged to continue to maintain social distancing.

Is COVID-19 Immunization Recommended for People With Kidney Disease?

COVID-19 vaccine should be recommended and not contraindicated in people with kidney disease (including kidney disease). Based on the following review, this recommendation is made:

• The National Immunization Advisory Committee recommends that people with weakened immune systems can get this. Vaccines were offered when the benefits of the vaccine outweighed the potential risks.

• People with kidney disease are at increased risk of hospitalization and death related to COVID-19.

• The Canadian Nephrology Society has endorsed and supported using the COVID-19 vaccine in this population.

• It was appealed to all federal states and governments to urgently prioritize dialysis patients due to COVID-19 Immunization.

• No risk of allergic reactions, except for the very rare risk of allergic reactions (so far, only a few people).

• Vaccines adversely affect kidney patients. There is only uncertainty as to its effectiveness in people who are Immunosuppressed.

• Those who have been affected by the new coronavirus infection.

Is the COVID-19 Vaccine Safe and Effective for People With Kidney Disease?

People with chronic kidney disease, including those on dialysis, are less likely to develop an adequate immune system. The response to the new coronavirus infection vaccine increases the risk of new coronavirus infection and serious complications. A study suggests that the third dose of the new coronavirus vaccine may cause a surge in immunocompromised patient’s antibody levels. A small study of the third dose of messenger ribonucleic acid (mRNA) COVID-19 vaccine demonstrates immunogenicity (immunity as measured in the blood) may increase with the 3rd dose. Currently, no known factors predispose people with chronic kidney disease to other diseases. Common adverse events as the environment with the expertise and equipment to treat anaphylaxis with minimal observation.

Are There Specific Considerations for Safe and Effective Administration?

1. For Kidney Transplant Waiting List - For those on the kidney transplant waiting list, there are some specific considerations related to the timing of immunization. It is recommended that immunization proceed as quickly as possible, given that the response to the vaccine is likely diminished in the immediate post-transplant period. Thus, completing immunization prior to transplant will be crucial for those high on the waiting list or those highly sensitized patients.

2. Patients on Immunosuppressive Therapy - The benefits of vaccination are believed to outweigh the potential risks. Vaccinations are recommended for:

• Preferably the group after completion of ‘induction’ therapy.

• Those who may have a serious systemic disease and require immunosuppressive therapy (Rituximab, Prednisone less than 20 milligrams per day, Cyclophosphamide, and plasmapheresis) must complete this course.

• Treatment should be obtained before vaccination, and treatment of life-threatening conditions should not be delayed to prevent this.

• In general, patients are preferred to complete immunizations before initiating high-dose immunosuppressive therapy. It is likely based on the timing of treatment and the availability of a vaccine at that time. Ideally, this should be at least 14 days after his second dose of either vaccine. Only life-saving or life-sustaining treatment should not be delayed to complete the vaccination.

3. For Hemodialysis Patients - The following considerations and recommendations for hemodialysis care should be taken into account as hemodialysis patients begin to receive vaccination against COVID-19. COVID-19 vaccines can be given concomitantly with or at any time before or after any other indicated vaccine. For new hemodialysis patients requiring screening:

• Blood samples may be sent for interferon-gamma release assays (IGRAs) testing if the patient has not had a COVID-19 vaccine dose in the last 28 days.

• IGRA testing should be deferred until 28 days after the most recent COVID-19 vaccine dose.

4. Special Consideration for Patients with Rituximab and Prednisone - Patients receiving these agents may have a blunted immune response to vaccines in general that can extend to up to six months following treatment completion:

• For patients on Rituximab, COVID-19 immunization should ideally be timed four to five months after their last infusion and two to four weeks prior to their next infusion, when possible, in order to optimize vaccine response.

• However, in patients that require immediate infusion or who are unable to optimize the timing of infusion product and vaccine, treatment is paramount. Patients should be counseled to get the vaccine as soon as it is available to them but to not delay Rituximab treatment for the sake of a vaccine appointment.

• For patients on Prednisone 20 milligrams per day or higher (or equivalents), consider waiting until the Prednisone dose is tapered to below 20 milligrams per day to receive both vaccine doses, but only if the time needed to taper the Prednisone dose below 20 milligrams per day is short. Pediatric patients on high-dose steroids should consult with their pediatric rheumatologist to decide on the best time to receive the vaccine.

Conclusion:

Vaccines are one of the most effective ways to protect health and prevent disease. Vaccines help boost the body's natural defenses to fight the virus when exposed (also called immunity). Although the COVID-19 vaccine has a very good efficacy rate, antibody immunity is not available in people taking immunosuppressive drugs to treat advanced kidney disease or in people who have had a kidney transplant. People on immunosuppressive therapy may not receive the same level of protection as the people who are not taking immunosuppressants are affected by the COVID-19 vaccine. Further research is required to know more about the efficacy of vaccines for patients with advanced CKD, people on dialysis, and transplant patients, but these vaccines have been shown to be safe in this population.